Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Eastman Chemical (EMN) Minority Interest (2016 - 2026)

Eastman Chemical (EMN) has disclosed Minority Interest for 16 consecutive years, with $77.0 million as the latest value for Q1 2026.

  • For Q1 2026, Minority Interest rose 5.48% year-over-year to $77.0 million; the TTM value through Mar 2026 reached $77.0 million, up 5.48%, while the annual FY2025 figure was $76.0 million, 4.11% up from the prior year.
  • Minority Interest hit $77.0 million in Q1 2026 for Eastman Chemical, up from $76.0 million in the prior quarter.
  • Across five years, Minority Interest topped out at $84.0 million in Q1 2022 and bottomed at $70.0 million in Q1 2024.
  • Average Minority Interest over 5 years is $75.4 million, with a median of $73.0 million recorded in 2024.
  • Year-over-year, Minority Interest decreased 15.48% in 2023 and then grew 5.48% in 2026.
  • Eastman Chemical's Minority Interest stood at $83.0 million in 2022, then decreased by 13.25% to $72.0 million in 2023, then grew by 1.39% to $73.0 million in 2024, then increased by 4.11% to $76.0 million in 2025, then rose by 1.32% to $77.0 million in 2026.
  • According to Business Quant data, Minority Interest over the past three periods came in at $77.0 million, $76.0 million, and $72.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.